Q'Apel Medical Inc., headquartered in Fremont, California, is an innovative neurovascular technology company focused on the development and commercialization of next-generation access technologies for vascular interventions.

Founded in 2016, Q'Apel Medical designs solutions aimed at addressing clinical needs in the field of neurovascular interventions. The company’s commitment to innovation is reflected in the development of its products, including “Armadillo” and “Walrus,” which represent significant advances in the management of emergency cases.

A neurointerventional guide catheter system with variable stiffness featuring a balloon at its distal tip. With dimensions of 0.087-inch ID and 8F+ (OD), it can function both as a catheter for introducing other catheters and as an introducer for thrombectomy devices. It provides stability at the proximal end while maintaining flexibility at the distal end, combining controlled flow, trackability, and stability in a single device.

The Walrus Balloon Guide Catheter is designed to provide optimal support and stability during complex neurovascular procedures, while offering improved navigation and control. Its innovative design ensures effective clot removal and excellent vessel wall apposition, making it a critical tool for stroke intervention.

Its robust construction enables the effective management of large vessel occlusions, facilitating smoother procedures and more successful outcomes for patients. The Walrus Balloon Guide Catheter reflects Q'Apel Medical’s commitment to advancing neurovascular therapies through cutting-edge technology, aiming to increase procedural success rates and improve patient recovery.

Armadillo is an innovative vascular access device developed by Q'Apel Medical, designed to provide stable and efficient access during complex neurovascular interventions.

It features a unique design that allows for a lower profile and the use of fewer catheters, significantly enhancing the ease and safety of procedures. This device is particularly beneficial in challenging cases, offering reliable access through its stability and flexibility.

Armadillo stands out for its ability to facilitate percutaneous access, a less invasive approach that improves patient comfort and recovery times. As part of Q'Apel Medical’s commitment to advancing neurovascular care, Armadillo embodies the company’s dedication to delivering cutting-edge technology that meets the specialized needs of healthcare professionals and patients.